RxBIO brings COVID-19 saliva collection kit with 99.998% accuracy to Europe
Spectrum Solutions system first to receive FDA emergency use authorization
DUBLIN, May 6, 2021 /PRNewswire/ A saliva collection kit that uses a pain-free method to test for COVID-19 is being distributed in Europe for the first time by RxBIO, a leading medical device distribution company.
Spectrum Solutions SDNA saliva collection kit offers a comfortable and more accurate alternative to the painful nasal swab test method for COVID-19. The kit received a CE Mark in December 2020 and is the first saliva-based system to receive Emergency Use Authorization for COVID-19 testing by the U.S. Food and Drug Administration.
Bridging Intellectual Opportunities
RxBIO brings COVID-19 saliva collection kit with 99.998% accuracy to Canadians
Testing for COVID-19 should be accurate, efficient and user-friendly – those are hallmarks of Spectrum Solutions’ saliva collection device” Jasmin Jetha, President and COO for RxBIORICHMOND HILL, ONTARIO, CANADA, May 6, 2021 /EINPresswire.com/ A saliva collection kit that uses a pain-free method to test for COVID-19 is being distributed in Canada for the first time by RxBIO Corp., a leading medical device distribution company. Spectrum Solutions’ SDNA saliva collection kit offers a comfortable and more accurate alternative to the painful nasal swab test method for COVID-19. Approved by Health Canada under Interim Order in January 2021, Spectrum’s SDNA saliva collection kit is the first saliva-based system to receive Emergency Use Authorization for COVID-19 testing by the U.S. Food and Drug Administration.